IDB confirms advanced Clal Insurance sale talks

The sale price of a 30% controlling stake to a Chinese investor at a company value of NIS 4.6 billion reflects a 25% premium.

IDB Holding Corp. Ltd. (TASE:IDBH), controlled by chairman Nochi Dankner, today notified the TASE that it was in advanced talks with a group of Chinese investors to sell 30% of Clal Insurance Enterprises Holdings Ltd. (TASE: CLIS) at a company value of NIS 4.6 billion.

The company value that IDB mentioned reflects a 25% premium on Clal Insurance's market cap. IDB Holding's wholly-owned subsidiary IDB Development owns 55% of the company.

IDB added that, under the terms of the deal, the buyer will acquire control of Clal Insurance, the parties will sign a shareholders agreement, which will include a put option for the sale of the rest of its stake in Clal Insurance to the buyer, and a call option by the buyer to acquire the rest of the stake.

The Tel Aviv District Court ordered IDB to sell half of 55% stake in Clal Insurance by August 22.

The TASE suspended trading in securities of Clal Insurance and IDB Holding and IDB Holding until 12:40 pm.

Hong Kong-based Hang Lung Group Ltd. (HKSE: 0010), controlled by chairman Ronnie Chen, which was reportedly interested in buying Clal Insurance has told "Bloomberg" that it is not the investor in talks with IDB.

Published by Globes [online], Israel business news - www.globes-online.com - on July 24, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018